Volume 13, Number 1—January 2007
Research
Vaccine Effectiveness Estimates, 2004–2005 Mumps Outbreak, England
Cheryl Cohen*1
, Joanne M. White†, Emma J. Savage†, Judith R. Glynn*, Yoon Choi†, Nick Andrews†, David Brown†, and Mary E. Ramsay†
, Joanne M. White†, Emma J. Savage†, Judith R. Glynn*, Yoon Choi†, Nick Andrews†, David Brown†, and Mary E. Ramsay†Table 3
Age-specific estimates of vaccine effectiveness for 1 and 2 doses of measles, mumps, rubella vaccine
| Age group, y | Effectiveness | |
|---|---|---|
| 1 dose, % (95% CI*) | 2 doses, % (95% CI*) | |
| 2 | 95.9 (81.1–99.1) | – |
| 5–6 | 93.8 (84.1–97.6) | 98.8 (97.0–99.5) |
| 7–8 | 90.3 (81.2–95.0) | 95.8 (92.9–97.5) |
| 9–10 | 86.5 (75.3–92.6) | 92.4 (87.7–95.3) |
| 11–12 | 65.9 (30.3–83.3) | 86.4 (74.1–92.9) |
*CI, confidence interval; p for linear trend <0.001 for 1 and 2 doses.
